Furthermore, clinical evidence from breast cancer patients shows that high HIF1α levels in primary tumors correlate with poor patient outcomes25–28, and a hypoxic transcriptomic signature in tumor cells is associated with bone metastasis29,30. This evidence concerns the gene HIF1A and breast carcinoma.